Research
Hormonal
Tirzepatide is a novel treatment option for Type 2 diabetes mellitus (T2DM) that may benefit individuals with cardiovascular disease or heart failure.
Tirzepatide may be considered for T2DM patients with cardiovascular concerns.
StrongSupportsmedium confidence
Tirzepatide is a dual agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors, constituting a novel treatment option in T2DM.
Why this rating
The abstract discusses current evidence, suggesting a strong basis for the claim.
Source
Tirzepatide for the Treatment of Heart Failure in Type 2 Diabetes Mellitus: (SUR)PASS, or Not?
Dimitrios Patoulias et al. · Future Cardiology · 2023
reviewCited 4×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →